Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancer.
Journal: Nature immunology
Published: June 25, 2025
Molecular genetics profiling of core-binding factor acute myeloid leukemia in pediatrics.
Journal: Therapeutic advances in hematology
Published: November 07, 2024
PPP1R7 Is a Novel Translocation Partner of CBFB via t(2;16)(q37;q22) in Acute Myeloid Leukemia.
Journal: Genes
Published: July 07, 2022
The imperfect storm: An uncommon presentation of Chagas disease.
Journal: The American journal of emergency medicine
Published: June 26, 2022
CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and Management.
Journal: Cancers
Published: October 02, 2021
Genetic alterations and expression characteristics of ARID1A impact tumor immune contexture and survival in early-onset gastric cancer.
Journal: American journal of cancer research
Published: August 23, 2020
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.
Journal: The Journal of clinical investigation
Published: May 21, 2019
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor Efficacy.
Journal: Cancer immunology research
Published: March 06, 2019
The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric Cancer.
Journal: Molecular cancer therapeutics
Published: July 25, 2018
PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness.
Journal: Cancer research
Published: April 03, 2018
Last Updated: 09/26/2026